We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+14.51%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.01%
AUM
$156B
AUM Growth
+$25.5B
Cap. Flow
+$7.96B
Cap. Flow %
5.1%
Top 10 Hldgs %
14.45%
Holding
3,256
New
111
Increased
2,472
Reduced
419
Closed
64

Top Buys

Rank Stock Value
1
KO icon
Coca-Cola
KO
+$443M
2
BMY icon
Bristol-Myers Squibb
BMY
+$300M
3
MSFT icon
Microsoft
MSFT
+$224M
4
AMZN icon
Amazon
AMZN
+$177M
5
DIS icon
Walt Disney
DIS
+$174M

Sector Composition

Rank Sector Weight
1 Technology 16.61%
2 Financials 13.9%
3 Healthcare 13%
4 Industrials 10.42%
5 Consumer Discretionary 10.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CARM
3126
DELISTED
Carisma Therapeutics
CARM
$50K ﹤0.01%
+2,418
New +$41.8K
MCHX icon
3127
Marchex
MCHX
$78M
$50K ﹤0.01%
+10,570
New +$43.2K
VNRX icon
3128
VolitionRx Ltd
VNRX
$9.31M
$50K ﹤0.01%
+769
New +$42.9K
VBIV
3129
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$50K ﹤0.01%
+876
New +$47.4K
TRVN
3130
DELISTED
Trevena, Inc.
TRVN
$50K ﹤0.01%
+51
New +$38.4K
AVXL icon
3131
Anavex Life Sciences
AVXL
$231M
$49K ﹤0.01%
+15,874
New +$37.9K
BCLI
3132
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$49K ﹤0.01%
+752
New +$42.8K
LUNA
3133
DELISTED
Luna Innovations Incorporated
LUNA
$49K ﹤0.01%
+11,699
New +$41.7K
CKPT
3134
DELISTED
Checkpoint Therapeutics
CKPT
$48K ﹤0.01%
+1,658
New +$52.9K
GNSS icon
3135
Genasys
GNSS
$76.5M
$48K ﹤0.01%
+16,638
New +$43.1K
PRPL icon
3136
Purple Innovation
PRPL
$34.5M
$48K ﹤0.01%
412
VERU icon
3137
Veru
VERU
$35.5M
$48K ﹤0.01%
+3,232
New +$46.4K
STCN
3138
DELISTED
Steel Connect, Inc. Common Stock
STCN
$48K ﹤0.01%
+2,533
New +$43.7K
TST
3139
DELISTED
TheStreet, Inc.
TST
$48K ﹤0.01%
+2,024
New +$44.3K
IRIX icon
3140
IRIDEX
IRIX
$15M
$47K ﹤0.01%
+10,210
New +$47.3K
LIQT icon
3141
LiqTech
LIQT
$20.5M
$47K ﹤0.01%
+675
New +$43.1K
LITS
3142
Lite Strategy Inc
LITS
$32.4M
$47K ﹤0.01%
+761
New +$43.6K
OTIC
3143
DELISTED
Otonomy, Inc.
OTIC
$47K ﹤0.01%
+17,686
New +$39.8K
HTGM
3144
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
$47K ﹤0.01%
+104
New +$45.5K
RIBT
3145
DELISTED
RiceBran Technologies
RIBT
$47K ﹤0.01%
+1,244
New +$41.7K
DALN
3146
DELISTED
DallasNews
DALN
$46K ﹤0.01%
+3,069
New +$48.5K
LFT
3147
Lument Finance Trust
LFT
$38.6M
$46K ﹤0.01%
+13,059
New +$44.2K
NGNE icon
3148
Neurogene
NGNE
$672M
$46K ﹤0.01%
+841
New +$42.5K
TGEN
3149
Tecogen Inc
TGEN
$89.8M
$46K ﹤0.01%
+11,344
New +$43.6K
APRN
3150
DELISTED
Blue Apron Holdings, Inc. Class A Common Stock
APRN
$46K ﹤0.01%
+260
New +$56.6K

Similar funds

Charles Schwab's Q1 2019 Portfolio in Review

As of Q1 2019, Charles Schwab held 3,256 positions worth $156B, up 20% from $131B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Charles Schwab deployed $7.96B of net new capital in Q1 2019, opening 111 new positions and adding to 2,472 existing holdings. Its largest new stake was Fox Class A: 1,745,328 shares worth $64.1M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Walmart Inc, an estimated $356M trimmed.

  • Charles Schwab's largest Q1 2019 buy was Fox Class A: 1,745,328 shares worth $64.1M.
  • Charles Schwab added most to Coca-Cola in Q1 2019, an estimated $443M increase.
  • Charles Schwab's biggest Q1 2019 reduction was Walmart Inc, cutting an estimated $356M.
  • Charles Schwab fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $213M.
  • Charles Schwab's ten largest holdings make up 14% of its $156B portfolio in Q1 2019.
  • Charles Schwab opened 111 new positions and closed 64 in Q1 2019.
  • Charles Schwab's portfolio value rose 20% quarter-over-quarter to $156B.

Based on Charles Schwab's 13F filing for Q1 2019, filed 14 May 2019.